Comparison of hypofractionated and conventional radiotherapy protocols in breast cancer patients: A retrospective study

Journal of Cancer Science and Therapy

Volumn 4, Issue 6, 2012, Pages 158-163

  El Sayed, Mohamed I ^a   Abdel Wanis, Mostafa E ^a  

^a ASSIUT UNIVERSITY   (Egypt)

Author keywords

Breast cancer; Fractionation; Survival

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HYPOFRACTIONATED RADIOTHERAPY; MAJOR CLINICAL STUDY; MEDICAL RECORD; OVERALL SURVIVAL; PNEUMONIA; RADIATION DERMATITIS; RETROSPECTIVE STUDY; SKIN TOXICITY; TREATMENT OUTCOME;

EID: 84902546168     PISSN: None     EISSN: 19485956     Source Type: Journal    
DOI: 10.4172/1948-5956.1000132     Document Type: Article

References (33)

1. Bankhead C (2008) Hypofractionated radiation in breast cancer has fewer adverse effects. MedPage Today.
2. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, et al. (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347: 1233-1241.
3. Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, et al. (2002) Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347: 1227-1232.
4. Plataniotis G (2010) Hypofractionated radiotherapy in the treatment of early breast cancer. World J Radiol 2: 197-202.
5. Ung YC, Sixel KE, Bell C (2000) The influence of patient geometry on the selection of chest wall irradiation techniques in post-mastectomy breast cancer patients. Radiother Oncol 57: 69-77.
6. Scott C, Paulus R, Stevens R, Marconi B, Champion L, et al. (1999) Is Radiation-Induced Skin Toxicity of the Breast Associated with Reduced Quality of Life: Report of RTOG 97-13. Proc Int Soc Quality Life Res 8: 65.
7. Yarnold J, Bentzen SM, Coles C, Haviland J (2011) Hypofractionated whole-breast radiotherapy for women with early breast cancer: myths and realities. Int J Radiat Oncol Biol Phys 79: 1-9.
8. Taher AN, El-Baradie MM, Essa H, Zaki O, Ezzat S, et al. (2004) Hypofractionation versus conventional fractionation radiotherapy after conservative treatment of breast cancer: early skin reactions and cosmetic results. J Egypt Natl Canc Inst 16: 178-187.
9. Archambeau JO, Pezner R, Wasserman T (1995) Pathophysiology of irradiated skin and breast. Int J Radiat Oncol Biol Phys 31: 1171-1185.
10. Awwad HK (1990) Dose-Time-Volume relationships in normal tissue to radiation. In Radiation Oncology: Radiobiological and Physiological Prespective. Kluwer Academic, Dordecht, Boston, London, 129-187.
11. Deantonio L, Gambaro G, Beldì D, Masini L, Tunesi S, et al. (2010) Hypofractionated radiotherapy after conservative surgery for breast cancer: analysis of acute and late toxicity. Radiat Oncol 5: 112.
12. Owen JR, Ashton A, Bliss JM, Homewood J, Harper C, et al. (2006) Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial. Lancet Oncol 7: 467-471.
13. Pinitpatcharalert A, Chitapanarux I, Euathrongchit J, Tharavichitkul E, Sukthomya V, et al. (2011) A retrospective study comparing hypofractionated radiotherapy and conventional radiotherapy in postmastectomy breast cancer. J Med Assoc Thai 94: S94-S102.
14. Dale RG (1985) The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy. Br J Radiol 58: 515-528.
15. Fowler JF (1989) The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 62: 679-694.
16. Sachs RK, Hahnfeld P, Brenner DJ (1997) The link between low-LET dose-response relations and the underlying kinetics of damage production/repair/misrepair. Int J Radiat Biol 72: 351-374.
17. Brenner DJ (2008) The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction. Semin Radiat Oncol 18: 234-239.
18. Kirkpatrick JP, Meyer JJ, Marks LB (2008) The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. Semin Radiat Oncol 18: 240-243.
19. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100: 3983-3988.
20. Alison MR, Lin WR, Lim SM, Nicholson LJ (2012) Cancer stem cells: In the line of fire. Cancer Treat Rev 38: 589-598.
21. Phillips TM, McBride WH, Pajonk F (2006) The response of CD24-/low/CD44 + breast cancer-initiating cells to radiation. J Natl Cancer Inst 98: 1777-1785.
22. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, et al. (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444: 756-760.
23. Diehn M, Clarke MF (2006) Cancer stem cells and radiotherapy: new insights into tumor radioresistance. J Natl Cancer Inst 98: 1755-1757.
24. Bahadur YA, Fawzy EE, Nasr AM (2006) Hypofractionated radiation therapy versus conventional radiation in the adjuvant setting of breast cancer; is there any difference in toxicity? Sci Med J ESCME 18: 1-12.
25. Schwartz GF, Birchansky CA, Komarnicky LT, Mansfield CM, Cantor RI, et al. (1994) Induction chemotherapy followed by breast conservation for locally advanced carcinoma of the breast. Cancer 73: 362-369.
26. Niikura N, Liu J, Hayashi N, Palla SL, Tokuda Y, et al. (2011) Treatment outcome and prognostic factors for patients with bone-only metastases of breast cancer: a single-institution retrospective analysis. Oncologist 16: 155-164.
27. Oyan B, Guler N, Kars A, Turker A, Al Tundag K, et al. (2002) The prognostic predictors for disease free survival and overall survival in stage I-III breast cancer patients treated with adjuvant cyclophosphamide-adriamycin-5-fluorouracil (CAF) chemotherapy. Turkish Journal of Cancer 32: 92-104.
28. Whelan T, MacKenzie R, Julian J, Levine M, Shelley W, et al. (2002) Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst 94: 1143-1150.
29. Whelan TJ, Pignol JP, Levine MN, Julian JA, MacKenzie R, et al. (2010) Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med 362: 513-520.
30. START Trialists' Group, Bentzen SM, Agrawal RK, Aird EG, Barrett JM, et al. (2008) The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol 9: 331-341.
31. START Trialists' Group, Bentzen SM, Agrawal RK, Aird EG, Barrett JM, et al. (2008) The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet 371: 1098-1107.
32. st Annual San Antonio Breast Cancer Symposium, San Antonio, TX.
33. Hopwood P, Haviland JS, Sumo G, Mills J, Bliss JM, et al. (2010) Comparison of patient-reported breast, arm, and shoulder symptoms and body image after radiotherapy for early breast cancer: 5-year follow-up in the randomised Standardisation of Breast Radiotherapy (START) trials. Lancet Oncol 11: 231-240.